nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiludronate—PTPN1—connective tissue—atherosclerosis	0.0127	0.253	CbGeAlD
Tiludronate—PTPN1—cardiovascular system—atherosclerosis	0.011	0.22	CbGeAlD
Tiludronate—PTPN1—adipose tissue—atherosclerosis	0.00971	0.194	CbGeAlD
Tiludronate—Rhinitis—Rosuvastatin—atherosclerosis	0.00738	0.0251	CcSEcCtD
Tiludronate—PTPN1—liver—atherosclerosis	0.00681	0.136	CbGeAlD
Tiludronate—ATP6V1A—adipose tissue—atherosclerosis	0.00581	0.116	CbGeAlD
Tiludronate—Arthralgia—Rosuvastatin—atherosclerosis	0.00546	0.0186	CcSEcCtD
Tiludronate—Myalgia—Rosuvastatin—atherosclerosis	0.00546	0.0186	CcSEcCtD
Tiludronate—Rhinitis—Niacin—atherosclerosis	0.00537	0.0183	CcSEcCtD
Tiludronate—Rhinitis—Pravastatin—atherosclerosis	0.00529	0.018	CcSEcCtD
Tiludronate—Back pain—Lovastatin—atherosclerosis	0.00525	0.0179	CcSEcCtD
Tiludronate—Back pain—Ezetimibe—atherosclerosis	0.00515	0.0175	CcSEcCtD
Tiludronate—Vertigo—Lovastatin—atherosclerosis	0.00488	0.0166	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00477	0.0162	CcSEcCtD
Tiludronate—Arthralgia—Lovastatin—atherosclerosis	0.00462	0.0157	CcSEcCtD
Tiludronate—Myalgia—Lovastatin—atherosclerosis	0.00462	0.0157	CcSEcCtD
Tiludronate—Dyspepsia—Rosuvastatin—atherosclerosis	0.00461	0.0157	CcSEcCtD
Tiludronate—Vertigo—Simvastatin—atherosclerosis	0.00457	0.0155	CcSEcCtD
Tiludronate—Myalgia—Ezetimibe—atherosclerosis	0.00454	0.0154	CcSEcCtD
Tiludronate—Arthralgia—Ezetimibe—atherosclerosis	0.00454	0.0154	CcSEcCtD
Tiludronate—Pain—Rosuvastatin—atherosclerosis	0.00447	0.0152	CcSEcCtD
Tiludronate—Arthralgia—Simvastatin—atherosclerosis	0.00433	0.0147	CcSEcCtD
Tiludronate—Myalgia—Simvastatin—atherosclerosis	0.00433	0.0147	CcSEcCtD
Tiludronate—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00428	0.0146	CcSEcCtD
Tiludronate—Vertigo—Niacin—atherosclerosis	0.00419	0.0143	CcSEcCtD
Tiludronate—Abdominal pain—Rosuvastatin—atherosclerosis	0.00414	0.0141	CcSEcCtD
Tiludronate—Vertigo—Pravastatin—atherosclerosis	0.00413	0.0141	CcSEcCtD
Tiludronate—ATP6V1A—liver—atherosclerosis	0.00408	0.0815	CbGeAlD
Tiludronate—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00404	0.0138	CcSEcCtD
Tiludronate—Arthralgia—Niacin—atherosclerosis	0.00397	0.0135	CcSEcCtD
Tiludronate—Myalgia—Niacin—atherosclerosis	0.00397	0.0135	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00396	0.0135	CcSEcCtD
Tiludronate—Myalgia—Pravastatin—atherosclerosis	0.00391	0.0133	CcSEcCtD
Tiludronate—Arthralgia—Pravastatin—atherosclerosis	0.00391	0.0133	CcSEcCtD
Tiludronate—Dyspepsia—Lovastatin—atherosclerosis	0.0039	0.0133	CcSEcCtD
Tiludronate—Dyspepsia—Ezetimibe—atherosclerosis	0.00383	0.013	CcSEcCtD
Tiludronate—Pain—Lovastatin—atherosclerosis	0.00379	0.0129	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00378	0.0129	CcSEcCtD
Tiludronate—Asthenia—Rosuvastatin—atherosclerosis	0.00375	0.0128	CcSEcCtD
Tiludronate—Pain—Ezetimibe—atherosclerosis	0.00372	0.0127	CcSEcCtD
Tiludronate—Dyspepsia—Simvastatin—atherosclerosis	0.00365	0.0124	CcSEcCtD
Tiludronate—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00363	0.0123	CcSEcCtD
Tiludronate—Diarrhoea—Rosuvastatin—atherosclerosis	0.00358	0.0122	CcSEcCtD
Tiludronate—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00356	0.0121	CcSEcCtD
Tiludronate—Pain—Simvastatin—atherosclerosis	0.00355	0.0121	CcSEcCtD
Tiludronate—Abdominal pain—Lovastatin—atherosclerosis	0.0035	0.0119	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00347	0.0118	CcSEcCtD
Tiludronate—Dizziness—Rosuvastatin—atherosclerosis	0.00346	0.0118	CcSEcCtD
Tiludronate—Abdominal pain—Ezetimibe—atherosclerosis	0.00344	0.0117	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00342	0.0116	CcSEcCtD
Tiludronate—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00339	0.0115	CcSEcCtD
Tiludronate—Dyspepsia—Niacin—atherosclerosis	0.00335	0.0114	CcSEcCtD
Tiludronate—Dyspepsia—Pravastatin—atherosclerosis	0.0033	0.0112	CcSEcCtD
Tiludronate—Abdominal pain—Simvastatin—atherosclerosis	0.00328	0.0112	CcSEcCtD
Tiludronate—Headache—Rosuvastatin—atherosclerosis	0.00328	0.0112	CcSEcCtD
Tiludronate—Pain—Niacin—atherosclerosis	0.00326	0.0111	CcSEcCtD
Tiludronate—Pain—Pravastatin—atherosclerosis	0.00321	0.0109	CcSEcCtD
Tiludronate—Asthenia—Lovastatin—atherosclerosis	0.00318	0.0108	CcSEcCtD
Tiludronate—Asthenia—Ezetimibe—atherosclerosis	0.00312	0.0106	CcSEcCtD
Tiludronate—Gastrointestinal pain—Niacin—atherosclerosis	0.00311	0.0106	CcSEcCtD
Tiludronate—Nausea—Rosuvastatin—atherosclerosis	0.00311	0.0106	CcSEcCtD
Tiludronate—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00307	0.0104	CcSEcCtD
Tiludronate—Diarrhoea—Lovastatin—atherosclerosis	0.00303	0.0103	CcSEcCtD
Tiludronate—Abdominal pain—Niacin—atherosclerosis	0.00301	0.0102	CcSEcCtD
Tiludronate—Asthenia—Simvastatin—atherosclerosis	0.00298	0.0101	CcSEcCtD
Tiludronate—Diarrhoea—Ezetimibe—atherosclerosis	0.00298	0.0101	CcSEcCtD
Tiludronate—Abdominal pain—Pravastatin—atherosclerosis	0.00296	0.0101	CcSEcCtD
Tiludronate—Dizziness—Lovastatin—atherosclerosis	0.00293	0.00998	CcSEcCtD
Tiludronate—Dizziness—Ezetimibe—atherosclerosis	0.00288	0.00979	CcSEcCtD
Tiludronate—Diarrhoea—Simvastatin—atherosclerosis	0.00284	0.00966	CcSEcCtD
Tiludronate—Headache—Lovastatin—atherosclerosis	0.00278	0.00946	CcSEcCtD
Tiludronate—Dizziness—Simvastatin—atherosclerosis	0.00274	0.00934	CcSEcCtD
Tiludronate—Asthenia—Niacin—atherosclerosis	0.00273	0.0093	CcSEcCtD
Tiludronate—Headache—Ezetimibe—atherosclerosis	0.00272	0.00927	CcSEcCtD
Tiludronate—Asthenia—Pravastatin—atherosclerosis	0.00269	0.00916	CcSEcCtD
Tiludronate—Nausea—Lovastatin—atherosclerosis	0.00263	0.00897	CcSEcCtD
Tiludronate—Diarrhoea—Niacin—atherosclerosis	0.00261	0.00887	CcSEcCtD
Tiludronate—Headache—Simvastatin—atherosclerosis	0.0026	0.00884	CcSEcCtD
Tiludronate—Nausea—Ezetimibe—atherosclerosis	0.00258	0.00879	CcSEcCtD
Tiludronate—Diarrhoea—Pravastatin—atherosclerosis	0.00257	0.00873	CcSEcCtD
Tiludronate—Dizziness—Niacin—atherosclerosis	0.00252	0.00857	CcSEcCtD
Tiludronate—Dizziness—Pravastatin—atherosclerosis	0.00248	0.00844	CcSEcCtD
Tiludronate—Nausea—Simvastatin—atherosclerosis	0.00246	0.00839	CcSEcCtD
Tiludronate—Headache—Niacin—atherosclerosis	0.00239	0.00812	CcSEcCtD
Tiludronate—Headache—Pravastatin—atherosclerosis	0.00235	0.008	CcSEcCtD
Tiludronate—Nausea—Niacin—atherosclerosis	0.00226	0.0077	CcSEcCtD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.00225	0.00344	CbGpPWpGaD
Tiludronate—Nausea—Pravastatin—atherosclerosis	0.00223	0.00758	CcSEcCtD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—IGF2—atherosclerosis	0.00221	0.00337	CbGpPWpGaD
Tiludronate—PTPN1—Leptin signaling pathway—STAT3—atherosclerosis	0.00218	0.00332	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—CLU—atherosclerosis	0.00218	0.00332	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Pathway—AKT1—atherosclerosis	0.00211	0.00322	CbGpPWpGaD
Tiludronate—PTPN1—Leptin signaling pathway—MAPK3—atherosclerosis	0.00208	0.00317	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—THBD—atherosclerosis	0.00205	0.00312	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.00203	0.00309	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—PIK3CG—atherosclerosis	0.00201	0.00306	CbGpPWpGaD
Tiludronate—PTPN1—Interferon Signaling—ICAM1—atherosclerosis	0.002	0.00304	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—PRKCG—atherosclerosis	0.00199	0.00303	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—MAPK3—atherosclerosis	0.00198	0.00301	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—VCAM1—atherosclerosis	0.00196	0.00299	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.00195	0.00297	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—CD36—atherosclerosis	0.00195	0.00296	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—SELE—atherosclerosis	0.00194	0.00296	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—SOCS3—atherosclerosis	0.0019	0.0029	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by PTP1B—AKT1—atherosclerosis	0.00188	0.00287	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—PDGFB—atherosclerosis	0.00179	0.00273	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IL18—atherosclerosis	0.00173	0.00264	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—VWF—atherosclerosis	0.00173	0.00264	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—APOA1—atherosclerosis	0.0017	0.00259	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—F7—atherosclerosis	0.00165	0.00251	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—F2—atherosclerosis	0.00162	0.00247	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—MAPK8—atherosclerosis	0.00158	0.00241	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—PIK3CG—atherosclerosis	0.00155	0.00236	CbGpPWpGaD
Tiludronate—PTPN1—Interferon Signaling—IFNG—atherosclerosis	0.00152	0.00232	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PLAT—atherosclerosis	0.00147	0.00224	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—MAPK3—atherosclerosis	0.00147	0.00224	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—STAT3—atherosclerosis	0.00145	0.0022	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—CETP—atherosclerosis	0.00144	0.0022	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—IGF1—atherosclerosis	0.00142	0.00216	CbGpPWpGaD
Tiludronate—PTPN1—Leptin signaling pathway—AKT1—atherosclerosis	0.0014	0.00214	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—MAPK3—atherosclerosis	0.00138	0.00211	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—SERPINE1—atherosclerosis	0.00135	0.00205	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—ALB—atherosclerosis	0.00134	0.00205	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—ICAM1—atherosclerosis	0.00133	0.00203	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—AKT1—atherosclerosis	0.00133	0.00203	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—MAPK8—atherosclerosis	0.0013	0.00198	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—KNG1—atherosclerosis	0.00129	0.00197	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—APOA4—atherosclerosis	0.00128	0.00196	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PLAUR—atherosclerosis	0.00128	0.00195	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.00127	0.00194	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PLG—atherosclerosis	0.00125	0.00191	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—SOD1—atherosclerosis	0.0012	0.00183	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—FCGR3A—atherosclerosis	0.0012	0.00182	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HRH1—atherosclerosis	0.00115	0.00175	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HRH1—atherosclerosis	0.00115	0.00175	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—IGF2—atherosclerosis	0.00114	0.00174	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—MAPK3—atherosclerosis	0.00113	0.00173	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—APOB—atherosclerosis	0.00111	0.00168	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—APOA2—atherosclerosis	0.0011	0.00168	CbGpPWpGaD
Tiludronate—PTPN1—Interferon Signaling—MAPK3—atherosclerosis	0.00109	0.00165	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—PLG—atherosclerosis	0.00108	0.00165	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—IL6—atherosclerosis	0.00107	0.00164	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PRKCG—atherosclerosis	0.00103	0.00156	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—BGN—atherosclerosis	0.00102	0.00156	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IFNG—atherosclerosis	0.00101	0.00155	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—CD36—atherosclerosis	0.001	0.00153	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—HMOX1—atherosclerosis	0.000999	0.00152	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—APOB—atherosclerosis	0.000957	0.00146	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—VEGFA—atherosclerosis	0.000926	0.00141	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PDGFB—atherosclerosis	0.000925	0.00141	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—MMP1—atherosclerosis	0.000914	0.00139	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IL1B—atherosclerosis	0.000905	0.00138	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—APOA4—atherosclerosis	0.000899	0.00137	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—APOA4—atherosclerosis	0.000899	0.00137	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CST3—atherosclerosis	0.00089	0.00136	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—CAV1—atherosclerosis	0.000876	0.00134	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—MAPK3—atherosclerosis	0.000876	0.00134	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—APOA1—atherosclerosis	0.000874	0.00133	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	0.00085	0.0013	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—NFKB1—atherosclerosis	0.000845	0.00129	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—NAMPT—atherosclerosis	0.000843	0.00128	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—NCF1—atherosclerosis	0.000838	0.00128	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—F2—atherosclerosis	0.000834	0.00127	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—APOC3—atherosclerosis	0.000832	0.00127	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CCL4—atherosclerosis	0.000828	0.00126	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CCL4—atherosclerosis	0.000828	0.00126	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—LDLR—atherosclerosis	0.000827	0.00126	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—NOS2—atherosclerosis	0.000824	0.00126	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—PPARA—atherosclerosis	0.000807	0.00123	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—HSPA1B—atherosclerosis	0.000799	0.00122	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PIK3CG—atherosclerosis	0.000798	0.00122	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CCR2—atherosclerosis	0.000791	0.00121	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CYBA—atherosclerosis	0.000788	0.0012	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—APOA2—atherosclerosis	0.000774	0.00118	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—APOA2—atherosclerosis	0.000774	0.00118	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—NCF1—atherosclerosis	0.000774	0.00118	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—AKT1—atherosclerosis	0.000765	0.00117	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—STAT3—atherosclerosis	0.000759	0.00116	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—APOA1—atherosclerosis	0.000757	0.00115	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—UTS2—atherosclerosis	0.000738	0.00112	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—UTS2—atherosclerosis	0.000738	0.00112	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CD40—atherosclerosis	0.000736	0.00112	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—TLR2—atherosclerosis	0.000736	0.00112	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—IGF1—atherosclerosis	0.000731	0.00111	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CYBA—atherosclerosis	0.000727	0.00111	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—MAPK3—atherosclerosis	0.000725	0.00111	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PARP1—atherosclerosis	0.000712	0.00108	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CX3CR1—atherosclerosis	0.000708	0.00108	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CASR—atherosclerosis	0.000708	0.00108	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CX3CR1—atherosclerosis	0.000708	0.00108	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CASR—atherosclerosis	0.000708	0.00108	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—SERPINE1—atherosclerosis	0.000694	0.00106	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CX3CL1—atherosclerosis	0.000694	0.00106	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CX3CL1—atherosclerosis	0.000694	0.00106	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—ALB—atherosclerosis	0.000693	0.00106	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CD14—atherosclerosis	0.000663	0.00101	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—NOS3—atherosclerosis	0.000663	0.00101	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CNR2—atherosclerosis	0.000658	0.001	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CNR2—atherosclerosis	0.000658	0.001	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—VCAM1—atherosclerosis	0.00064	0.000975	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—SOCS3—atherosclerosis	0.000621	0.000946	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—ALB—atherosclerosis	0.0006	0.000914	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	0.000591	0.000901	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—VWF—atherosclerosis	0.000586	0.000893	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—VWF—atherosclerosis	0.000586	0.000893	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—APOC3—atherosclerosis	0.000583	0.000888	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—APOC3—atherosclerosis	0.000583	0.000888	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—LDLR—atherosclerosis	0.000579	0.000883	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—LDLR—atherosclerosis	0.000579	0.000883	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL18—atherosclerosis	0.000566	0.000862	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CCL3—atherosclerosis	0.000566	0.000862	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CCL3—atherosclerosis	0.000566	0.000862	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CD40LG—atherosclerosis	0.000564	0.000859	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—AGER—atherosclerosis	0.000544	0.000828	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NCF1—atherosclerosis	0.000542	0.000826	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NCF1—atherosclerosis	0.000542	0.000826	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PRKCG—atherosclerosis	0.000538	0.00082	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—APOB—atherosclerosis	0.000535	0.000815	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IL6—atherosclerosis	0.00053	0.000808	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CD36—atherosclerosis	0.000526	0.000801	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—EDNRA—atherosclerosis	0.000512	0.00078	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CCR2—atherosclerosis	0.000512	0.00078	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—EDNRA—atherosclerosis	0.000512	0.00078	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CCR2—atherosclerosis	0.000512	0.00078	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—LPL—atherosclerosis	0.000511	0.000779	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CYBA—atherosclerosis	0.000509	0.000776	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CYBA—atherosclerosis	0.000509	0.000776	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PLAT—atherosclerosis	0.000499	0.00076	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PLAT—atherosclerosis	0.000499	0.00076	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PARP1—atherosclerosis	0.000499	0.00076	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—GHRL—atherosclerosis	0.000499	0.00076	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PARP1—atherosclerosis	0.000499	0.00076	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—GHRL—atherosclerosis	0.000499	0.00076	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PRKCG—atherosclerosis	0.000497	0.000757	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PDGFB—atherosclerosis	0.000485	0.000739	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—VEGFA—atherosclerosis	0.000477	0.000728	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CRP—atherosclerosis	0.000474	0.000722	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MTHFR—atherosclerosis	0.00046	0.000701	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—TLR4—atherosclerosis	0.000454	0.000693	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—MAPK3—atherosclerosis	0.000452	0.000688	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PDGFB—atherosclerosis	0.000448	0.000682	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—TGFB1—atherosclerosis	0.000438	0.000668	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—KNG1—atherosclerosis	0.000438	0.000667	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—KNG1—atherosclerosis	0.000438	0.000667	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—ICAM1—atherosclerosis	0.000436	0.000664	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—AGTR1—atherosclerosis	0.000435	0.000663	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—AGTR1—atherosclerosis	0.000435	0.000663	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—APOE—atherosclerosis	0.000428	0.000653	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CAV1—atherosclerosis	0.000424	0.000647	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PLG—atherosclerosis	0.000424	0.000646	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PLG—atherosclerosis	0.000424	0.000646	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—APOA1—atherosclerosis	0.000423	0.000645	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SOCS3—atherosclerosis	0.000401	0.000612	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SOCS3—atherosclerosis	0.000401	0.000612	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—NOS2—atherosclerosis	0.000399	0.000608	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MMP3—atherosclerosis	0.000388	0.000591	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MMP3—atherosclerosis	0.000388	0.000591	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IGF2—atherosclerosis	0.000386	0.000588	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IGF2—atherosclerosis	0.000386	0.000588	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—APOB—atherosclerosis	0.000375	0.000571	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—APOB—atherosclerosis	0.000375	0.000571	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—EDN1—atherosclerosis	0.000369	0.000562	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—EDN1—atherosclerosis	0.000369	0.000562	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CCL5—atherosclerosis	0.000366	0.000558	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CCL5—atherosclerosis	0.000366	0.000558	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—INS—atherosclerosis	0.000366	0.000558	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—LPL—atherosclerosis	0.000358	0.000545	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—LPL—atherosclerosis	0.000358	0.000545	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PRKCG—atherosclerosis	0.000348	0.00053	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PRKCG—atherosclerosis	0.000348	0.00053	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SPP1—atherosclerosis	0.000339	0.000516	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SPP1—atherosclerosis	0.000339	0.000516	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—SERPINE1—atherosclerosis	0.000336	0.000512	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IFNG—atherosclerosis	0.000332	0.000505	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—NOS3—atherosclerosis	0.000321	0.000489	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PDGFB—atherosclerosis	0.000314	0.000478	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PDGFB—atherosclerosis	0.000314	0.000478	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—AGT—atherosclerosis	0.000306	0.000466	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—AGT—atherosclerosis	0.000306	0.000466	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—AKT1—atherosclerosis	0.000305	0.000464	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—APOE—atherosclerosis	0.0003	0.000457	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—LEP—atherosclerosis	0.0003	0.000457	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—APOE—atherosclerosis	0.0003	0.000457	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—LEP—atherosclerosis	0.0003	0.000457	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CAV1—atherosclerosis	0.000297	0.000453	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CAV1—atherosclerosis	0.000297	0.000453	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—APOA1—atherosclerosis	0.000296	0.000452	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—APOA1—atherosclerosis	0.000296	0.000452	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL1B—atherosclerosis	0.000296	0.000451	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PTGS2—atherosclerosis	0.000293	0.000447	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ESR1—atherosclerosis	0.000286	0.000436	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ESR1—atherosclerosis	0.000286	0.000436	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—F2—atherosclerosis	0.000283	0.000431	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—F2—atherosclerosis	0.000283	0.000431	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—NFKB1—atherosclerosis	0.000276	0.00042	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—MAPK8—atherosclerosis	0.000271	0.000413	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PIK3CG—atherosclerosis	0.000271	0.000412	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PIK3CG—atherosclerosis	0.000271	0.000412	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—INS—atherosclerosis	0.000256	0.00039	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—INS—atherosclerosis	0.000256	0.00039	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CCL2—atherosclerosis	0.000252	0.000384	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CCL2—atherosclerosis	0.000252	0.000384	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—STAT3—atherosclerosis	0.000248	0.000378	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IGF1—atherosclerosis	0.000248	0.000378	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IGF1—atherosclerosis	0.000248	0.000378	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—MAPK3—atherosclerosis	0.000237	0.000361	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SERPINE1—atherosclerosis	0.000235	0.000359	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SERPINE1—atherosclerosis	0.000235	0.000359	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—STAT3—atherosclerosis	0.000229	0.000349	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NOS3—atherosclerosis	0.000225	0.000342	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NOS3—atherosclerosis	0.000225	0.000342	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MAPK3—atherosclerosis	0.000219	0.000333	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—TGFB1—atherosclerosis	0.000212	0.000323	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CXCL8—atherosclerosis	0.000199	0.000304	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CXCL8—atherosclerosis	0.000199	0.000304	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MMP9—atherosclerosis	0.00018	0.000275	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MMP9—atherosclerosis	0.00018	0.000275	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NFKB1—atherosclerosis	0.000178	0.000272	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NFKB1—atherosclerosis	0.000178	0.000272	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MAPK8—atherosclerosis	0.000175	0.000267	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MAPK8—atherosclerosis	0.000175	0.000267	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL6—atherosclerosis	0.000173	0.000264	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—VEGFA—atherosclerosis	0.000162	0.000247	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—VEGFA—atherosclerosis	0.000162	0.000247	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—STAT3—atherosclerosis	0.00016	0.000244	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—STAT3—atherosclerosis	0.00016	0.000244	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—IL6—atherosclerosis	0.00016	0.000244	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—AKT1—atherosclerosis	0.00016	0.000243	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MAPK3—atherosclerosis	0.000153	0.000233	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MAPK3—atherosclerosis	0.000153	0.000233	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TGFB1—atherosclerosis	0.000149	0.000226	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TGFB1—atherosclerosis	0.000149	0.000226	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—AKT1—atherosclerosis	0.000147	0.000225	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IL6—atherosclerosis	0.000112	0.000171	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IL6—atherosclerosis	0.000112	0.000171	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—AKT1—atherosclerosis	0.000103	0.000157	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—AKT1—atherosclerosis	0.000103	0.000157	CbGpPWpGaD
